Clinical Trials for Oncovir

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Oncovir

Clinical Trials (6)

NCT06782932
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
PHASE1/PHASE2Recruiting
38 participants
Started: May 27, 2025 · Completed: Dec 31, 2028
1 condition4 sponsors1 location
NCT05950139
Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC
PHASE1/PHASE2Recruiting
12 participants
Started: May 13, 2024 · Completed: Jul 31, 2029
2 conditions2 sponsors1 location
NCT06343077
Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance
PHASE2Recruiting
114 participants
Started: Jan 16, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT03219450
A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.
PHASE1Recruiting
15 participants
Started: Aug 18, 2021 · Completed: Mar 31, 2028
1 condition4 sponsors1 location
NCT04201873
Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
PHASE1Active, not recruiting
40 participants
Started: Jan 8, 2020 · Completed: Aug 1, 2027
1 condition5 sponsors1 location
NCT02950766
NeoVax Plus Ipilimumab in Renal Cell Carcinoma
PHASE1Active, not recruiting
19 participants
Started: Mar 3, 2019 · Completed: May 30, 2030
1 condition3 sponsors1 location